Product Reports Resources Pricing Login Book a demo

DNA Script

Biotech & Life Sciences · Le Kremlin-Bicêtre, France · Founded 2014

Transforming how molecular biology translates to human health, personalized medicine, and synthetic biology MoreLess

DNA Script revolutionizes DNA synthesis with its proprietary enzymatic technology. The company has developed SYNTAX™️, the world's first benchtop DNA printer, which integrates innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. DNA Script serves clients in genomics research and personalized medicine, providing a cutting-edge tool that simplifies and accelerates DNA synthesis. Operating in the biotechnology market, the company generates revenue through the sale of its SYNTAX™️ system and related consumables. By enabling rapid and efficient DNA synthesis, DNA Script aims to drive advancements in genomics and personalized healthcare.

Keywords: DNA synthesis, enzymatic technology, benchtop printer, genomics research, personalized medicine, enzyme engineering, nucleotide chemistries, biotechnology, SYNTAX system, healthcare.

Valuation $500M–1B
Revenue $10–50M
Headcount 100–500
Total funding $100–500M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for DNA Script and the history behind them.

Talent graph

DNA Script's talent

Book a demo to see the people
Team profiled 19 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

24 investors on DNA Script's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 5 investors entered at this stage
Kurma Partners
Sofinnova Partners
Eurazeo
Bpifrance
European Innovation Council
Series A 6 investors entered at this stage
Illumina Ventures
M Ventures
EQT Life Sciences
Casdin Capital
Agilent
Danaher
Series B+ 13 investors entered at this stage
Catalio Capital Management
Coatue Management
Farallon Capital Management
Alexandria Venture Investments
ArrowMark Partners
Columbia Threadneedle Investments
Fidelity Investments
Moore Strategic Ventures
Baillie Gifford
T. Rowe Price
Irving Investors
EureKARE
HealthCor Management

Global footprint

Where DNA Script has talent and traffic

Workforce by country
3 countries with
team presence
🇫🇷 France84.6%
🇺🇸 United States14.4%
🇩🇪 Germany1%
3 countries shown

Market sentiment

What the market is saying about DNA Script

An AI-synthesized read of the highest-engagement posts about DNA Script on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See DNA Script on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.